Diana De Graeve
Diana De Graeve
professor of economics University of Antwerpen
Verified email at uantwerpen.be - Homepage
TitleCited byYear
Equity in the delivery of health care in Europe and the US
E Van Doorslaer, A Wagstaff, H Van der Burg, T Christiansen, ...
Journal of health economics 19 (5), 553-583, 2000
6902000
Does inequality in self-assessed health predict inequality in survival by income? Evidence from Swedish data
E Van Doorslaer, UG Gerdtham
Social science & medicine 57 (9), 1621-1629, 2003
427*2003
A typology for provider payment systems in health care
M Jegers, K Kesteloot, D De Graeve, W Gilles
Health policy 60 (3), 255-273, 2002
2162002
Cost-effectiveness of pneumococcal vaccination of older people: a study in 5 western European countries
A Ament, R Baltussen, G Duru, C Rigaud-Bully, D De Graeve, ┼ Írtqvist, ...
Clinical Infectious Diseases 31 (2), 444-450, 2000
1812000
Cost-effectiveness of pneumococcal vaccination of older people: a study in 5 western European countries
A Ament, R Baltussen, G Duru, C Rigaud-Bully, D De Graeve, ┼ Írtqvist, ...
Clinical Infectious Diseases 31 (2), 444-450, 2000
1812000
Optimal zone boundaries for two-class-based compact three-dimensional automated storage and retrieval systems
Y Yu, RBM de Koster
IIE Transactions 41 (3), 194-208, 2009
672009
The distributional impact of health financing in Europe: a review
D De Graeve, T Van Ourti
World Economy 26 (10), 1459-1479, 2003
622003
Long-acting risperidone compared with oral olanzapine and haloperidol depot in schizophrenia: a Belgian cost-effectiveness analysis
D De Graeve, A Smet, A Mehnert, S Caleo, H Miadi-Fargier, ...
Pharmacoeconomics 23 (1), 35-47, 2005
572005
Supplemental health insurance and equality of access in Belgium
E Schokkaert, T Van Ourti, D De Graeve, A Lecluyse, C Van de Voorde
Health economics 19 (4), 377-395, 2010
462010
Healthcare use, social burden and costs of children with and without ADHD in Flanders, Belgium
A De Ridder, D De Graeve
Clinical drug investigation 26 (2), 75-90, 2006
462006
Healthcare use, social burden and costs of children with and without ADHD in Flanders, Belgium
A De Ridder, D De Graeve
Clinical drug investigation 26 (2), 75-90, 2006
462006
Economic aspects of pneumococcal pneumonia
D De Graeve, P Beutels
Pharmacoeconomics 22 (11), 719-740, 2004
382004
The economics of health insurance in low and middle-income countries
D De Graeve
361999
Direct costs of health care for HIV/AIDS patients in Belgium
RC Decock, AME Depoorter, DD Graeve, R Colebunders
AIDS care 13 (6), 721-731, 2001
322001
Cost-effectiveness analysis of pneumococcal vaccination of adults and elderly persons in Belgium
D De Graeve, G Lombaert, H Goossens
Pharmacoeconomics 17 (6), 591-601, 2000
272000
Experience: the most critical factor in choosing after-hours medical care
H Philips, D Mahr, R Remmen, M Weverbergh, D De Graeve, ...
Qual Saf Health Care 19 (6), e3-e3, 2010
222010
Drug eluting stents in Belgium: health technology assessment
M Neyt, H Van Brabandt, S Devriese, J Mahieu, A De Ridder, ...
Brussel: Federaal Kenniscentrum voor de Gezondheidszorg, 2007
212007
Evaluatie van de effecten van de maximumfactuur op de consumptie en financiŰle toegankelijkheid van gezondheidszorg
E Schokkaert, J Guillaume, A Lecluyse, H Avalosse, K Cornelis, ...
172008
Recommended structure for reporting economic evaluation on pharmaceuticals in Belgium
L Annemans, R Crott, D Degraeve, D Dubois, M Huybrechts, F Peys, ...
Pharmacy World and Science 24 (1), 5-7, 2002
172002
Belgian Schizophrenia Outcome Survey–Results of a 2-year naturalistic study in patients stabilised on monotherapy with olanzapine, risperidone or haloperidol
J Peuskens, B Gillain, D De Graeve, B Van Vleymen, A Albert
European Psychiatry 24 (3), 154-163, 2009
152009
The system can't perform the operation now. Try again later.
Articles 1–20